
Outlook Therapeutics OTLK
$ 0.23
-4.1%
Quarterly report 2025-Q4
added 02-17-2026
Outlook Therapeutics ROE Ratio 2011-2026 | OTLK
Annual ROE Ratio Outlook Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103.13 | 408.53 | -756.04 | -1153.86 | -1246.85 | 320.56 | 144.6 | 126.44 | 1025.53 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1025.53 | -1246.85 | -114.22 |
Quarterly ROE Ratio Outlook Therapeutics
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 310.99 | 162.44 | 109.36 | 2.1 | -55.56 | 77.98 | 453.7 | 882.49 | 733.9 | 193.84 | -398.01 | -861.07 | -852.41 | -763.6 | -1034.68 | -1043.01 | -1051.68 | -884.06 | -916.93 | -792.48 | -591.01 | -675.34 | 371.91 | 370.66 | 286.33 | 269.62 | 188.22 | 193.69 | 178.15 | 148.84 | 175.31 | 158.14 | 125.71 | 205.54 | 935.14 | 1348.66 | 1710.22 | 1678.5 | 908.14 | 499.69 | 76.67 | 76.67 | 20.92 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1710.22 | -1051.68 | 68.23 |
ROE Ratio of other stocks in the Biotechnology industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
-528.29 | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
15.76 | - | 2.43 % | $ 254 M | ||
|
MannKind Corporation
MNKD
|
-11.49 | $ 3.56 | 24.48 % | $ 1.09 B | ||
|
AgeX Therapeutics
AGE
|
51843.24 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
-85.31 | - | - | $ 866 M | ||
|
Bio-Techne Corporation
TECH
|
3.83 | $ 47.41 | -16.36 % | $ 7.47 B | ||
|
United Therapeutics Corporation
UTHR
|
18.81 | $ 596.76 | 4.29 % | $ 26.4 B | ||
|
Midatech Pharma plc
MTP
|
-330.29 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
5.18 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
-751.94 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
626.29 | - | 2.54 % | $ 160 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-115.61 | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
-380.03 | - | - | $ 269 M | ||
|
BioNTech SE
BNTX
|
1.11 | - | - | $ 27.2 B | ||
|
Институт стволовых клеток человека
ISKJ
|
17.55 | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
-88.4 | - | - | $ 231 M | ||
|
INmune Bio
INMB
|
-195.26 | $ 1.52 | -1.3 % | $ 37.6 M | ||
|
Exelixis
EXEL
|
36.21 | $ 48.7 | 9.64 % | $ 13.2 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
30.9 | $ 21.48 | -3.89 % | $ 3.56 B | ||
|
Fortress Biotech
FBIO
|
13.66 | - | - | $ 71.1 M | ||
|
Advaxis
ADXS
|
196.88 | - | -9.65 % | $ 45.9 M | ||
|
Esperion Therapeutics
ESPR
|
7.51 | $ 3.15 | 1.19 % | $ 655 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-175.75 | - | - | $ 5.51 M | ||
|
Aeterna Zentaris
AEZS
|
-401.79 | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-21.7 | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
-59.8 | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-62.37 | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
-32.34 | - | 1.93 % | $ 17.4 M | ||
|
Akero Therapeutics
AKRO
|
-33.6 | - | - | $ 3.67 B | ||
|
Aptose Biosciences
APTO
|
93.75 | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
-169.38 | - | -39.0 % | $ 4.57 M | ||
|
Akouos
AKUS
|
-37.09 | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
-19.38 | - | -0.23 % | $ 916 M | ||
|
Allakos
ALLK
|
-110.0 | - | - | $ 28.6 M | ||
|
AlloVir
ALVR
|
-55.11 | - | 4.14 % | $ 49.1 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-8.52 | $ 24.17 | 3.2 % | $ 3.08 B | ||
|
Allena Pharmaceuticals
ALNA
|
-257.91 | - | 3.16 % | $ 1.9 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-256.9 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
-207.64 | - | - | $ 10.1 M | ||
|
Alpine Immune Sciences
ALPN
|
-32.19 | - | - | $ 2.17 B | ||
|
Aileron Therapeutics
ALRN
|
-294.78 | - | 10.36 % | $ 9.8 M | ||
|
Applied Therapeutics
APLT
|
698.49 | - | - | $ 8.42 M | ||
|
Aravive
ARAV
|
-716.17 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
125.33 | - | 17.91 % | $ 11.1 M | ||
|
CRISPR Therapeutics AG
CRSP
|
-30.26 | $ 55.08 | 5.15 % | $ 4.95 B | ||
|
Avenue Therapeutics
ATXI
|
-158.79 | - | -52.27 % | $ 4.45 M | ||
|
Autolus Therapeutics plc
AUTL
|
-161.42 | $ 1.7 | 3.66 % | $ 452 M | ||
|
AVROBIO
AVRO
|
12.83 | - | 1083.1 % | $ 745 M | ||
|
Ayala Pharmaceuticals
AYLA
|
3458.87 | - | - | $ 7.46 M | ||
|
Завод ДИОД
DIOD
|
3.1 | - | - | - |